Leadership of Drug Enforcement Administration turning over again

The acting head of the Drug Enforcement Administration is stepping down, less than nine months into the position, raising fresh uncertainties about the Trump administration’s marijuana policy.

Robert Patterson told employees in an email Monday that the ability to chart the federal drug agency’s priorities had become “increasingly challenging” in his acting capacity, according to The Washington Post.

It’s unclear what the next DEA head’s stance will be on marijuana, but Patterson recently had taken a hard line.

According to The Hill, Patterson claimed during a hearing last month before Congress that he didn’t know about a highly publicized study in the Journal of the American Medical Association that found medical marijuana legalization is associated with declines in opioid-related mortality.

Also at that hearing, he said he was concerned the United States was “going down a bad path with marijuana” and too focused on cannabis as a revenue generator.

That position was different from that of his predecessor, Chuck Rosenberg, who had butted heads with U.S. Attorney General Jeff Sessions over cannabis research policy.

Rosenberg also served as an acting DEA chief, rather than a permanent one confirmed by the U.S. Senate.

Patterson, who worked for the DEA for three decades, told employees he plans to retire in about two weeks.

9 comments on “Leadership of Drug Enforcement Administration turning over again
  1. David Christian on

    Utilize for it’s benefits that out way any negative actualization. Make America Great Again through legalized Marijuana/Hemp industry. Let’s industrialize!!!

    Reply
  2. Christian on

    It’s time for the anti-marijuana heads to leave all levels of government. They govern by their bias on a plant that as been demonized for far too long. They are paid by big pharma, tobacco, and liquor. So no matter how many studies come out about the benefits of marijuana, their stance will never change.

    Reply
    • James Dixon on

      It’s about time to pay attention to the public rather than companies–tobacco and alcohol–who contribute to election campaigns of those who ignore scientific studies of marijuana and its effects on users. No one has ever died from an marijuana ‘overdose’, but many have died from tobacco and alcohol.

      Clean out the government yes-men/women and replace with non-biased-and non-bought responsible to the public officials…..

      Reply
  3. Theresa on

    The fact that the head DEA guy said ” that he didn’t know about a highly publicized study in the Journal of the American Medical Association that found medical marijuana legalization is associated with declines in opioid-related mortality.” is proof he needs to be replaced. He is very apparently out of touch with reality. Please replace him with someone who sees the benefits of deregulation of marijuana. It will free up alot of time to be spent on other avenues.

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *